Pembrolizumab-induced immune-mediated fatal colitis with concurrent giardia infection
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-020-02815-1
Abstract: Advancements in medicine have enabled the use of monoclonal antibodies in the field of oncology. However, the new adverse effects of immunotherapeutic agents are still being reported. We present the first case of pembrolizumab-induced fatal… read more here.
Keywords: colitis concurrent; concurrent giardia; fatal colitis; colitis ... See more keywords